173 related articles for article (PubMed ID: 11871141)
1. [Arbekacin resistant gene, aacA/aphD, in Staphylococcus aureus is lost during in vitro passage].
Chen G; Fukuchi K; Wakuta R; Kubo S; Yasuhara T; Takagi Y; Gomi K
Rinsho Byori; 2002 Jan; 50(1):79-84. PubMed ID: 11871141
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus.
Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M
FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
5. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
Suzuki T; Fujita K; Nagamachi Y; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of nosocomial multiple-aminoglycoside-resistant Staphylococcus aureus caused by horizontal transfer of the resistance determinant (aacA/aphD) and clonal spread of resistant strains.
Udou T
Am J Infect Control; 2004 Jun; 32(4):215-9. PubMed ID: 15175616
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
10. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
[TBL] [Abstract][Full Text] [Related]
11. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Kono K; Takeda S; Tatara I; Arakawa K
Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179
[TBL] [Abstract][Full Text] [Related]
13. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A
J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784
[No Abstract] [Full Text] [Related]
14. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
[TBL] [Abstract][Full Text] [Related]
15. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Watanabe T; Ohashi K; Matsui K; Kubota T
J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
[TBL] [Abstract][Full Text] [Related]
17. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
[TBL] [Abstract][Full Text] [Related]
18. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
[TBL] [Abstract][Full Text] [Related]
19. [The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillin-cephem-resistant Staphylococcus aureus].
Matsuhashi Y; Yamamoto H
Jpn J Antibiot; 1988 May; 41(5):523-9. PubMed ID: 3216474
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain.
Inouye Y; Morifuji K; Masumi N; Nakamura S; Takesue Y; Santou T; Yokoyama T
Hiroshima J Med Sci; 1992 Dec; 41(4):79-85. PubMed ID: 1293073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
